Fermentation Development And Manufacturing

Scaling a fermentation process from early development to commercial GMP manufacturing is one of the most technically demanding challenges in pharmaceutical and biotech production. Managing strain performance, process consistency, and downstream complexity across multiple scales requires deep expertise and infrastructure that few CDMOs can deliver under one roof. Curia's integrated fermentation platform spans the full development continuum, from strain improvement and cell banking through process development, scale-up, and GMP manufacturing at volumes up to 40,000 L.

Across three specialized European sites in León, San Cristóbal, and Rozzano, you gain access to 22 development-scale fermenters, pilot scale-up from 600 L to 15,000 L, and GMP manufacturing with intermediate vessel sizes to match your exact production needs. The platform covers pharmaceutical APIs, including antibiotics, immunosuppressants, antifungals, cannabinoids, and steroids, as well as consumer goods and specialized products like recombinant proteins. Biocatalytic processes are integrated with advanced chemical synthesis to create greener, more cost-effective routes, with GMO capabilities and food certifications available where required.

Whether you are navigating early feasibility or preparing for commercial launch, Curia's multidisciplinary teams tailor each approach to your molecule and your timeline. Download the brochure now to explore the full scope of Curia's fermentation development and manufacturing capabilities.